首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Non-mutagenic Suppression of Enterocyte Ferroportin 1 by Chemical Ribosomal Inactivation via p38 Mitogen-activated Protein Kinase (MAPK)-mediated Regulation
【2h】

Non-mutagenic Suppression of Enterocyte Ferroportin 1 by Chemical Ribosomal Inactivation via p38 Mitogen-activated Protein Kinase (MAPK)-mediated Regulation

机译:通过p38丝裂原活化蛋白激酶(MAPK)介导的调节的化学核糖体失活对肠上皮细胞铁转运蛋白1的非诱变抑制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Iron transfer across the basolateral membrane of an enterocyte into the circulation is the rate-limiting step in iron absorption and is regulated by various pathophysiological factors. Ferroportin (FPN), the only known mammalian iron exporter, transports iron from the basolateral surface of enterocytes, macrophages, and hepatocytes into the blood. Patients with genetic mutations in FPN or repeated blood transfusion develop hemochromatosis. In this study, non-mutagenic ribosomal inactivation was assessed as an etiological factor of FPN-associated hemochromatosis in enterocytes. Non-mutagenic chemical ribosomal inactivation disrupted iron homeostasis by regulating expression of the iron exporter FPN-1, leading to intracellular accumulation in enterocytes. Mechanistically, a xenobiotic insult stimulated the intracellular sentinel p38 MAPK signaling pathway, which was positively involved in FPN-1 suppression by ribosomal dysfunction. Moreover, ribosomal inactivation-induced iron accumulation in Caenorhabditis elegans as a simplified in vivo model for gut nutrition uptake was dependent on SEK-1, a p38 kinase activator, leading to suppression of FPN-1.1 expression and iron accumulation. In terms of gene regulation, ribosomal stress-activated p38 signaling down-regulated NRF2 and NF-κB, both of which were positive transcriptional regulators of FPN-1 transcription. This study provides molecular evidence for the modulation of iron bioavailability by ribosomal dysfunction as a potent etiological factor of non-mutagenic environmental hemochromatosis in the gut-to-blood axis.
机译:铁穿过肠细胞的基底外侧膜转移到循环中是铁吸收的限速步骤,并受各种病理生理因素的调节。 Ferroportin(FPN)是唯一已知的哺乳动物铁出口商,将铁从肠上皮细胞,巨噬细胞和肝细胞的基底外侧表面转运到血液中。 FPN发生基因突变或反复输血的患者会出现血色素沉着症。在这项研究中,非诱变的核糖体失活被评估为肠上皮细胞中FPN相关性血色素沉着病的病因。非诱变化学核糖体失活通过调节铁输出FPN-1的表达来破坏铁稳态,导致肠内细胞内细胞内积累。从机制上讲,异源生物的刺激刺激了细胞内前哨p38 MAPK信号通路,该通路与核糖体功能障碍对FPN-1的抑制有积极作用。此外,秀丽隐杆线虫的核糖体失活诱导的铁蓄积作为肠道营养摄入的简化体内模型,依赖于p38激酶激活剂SEK-1,从而抑制了FPN-1.1的表达和铁蓄积。在基因调控方面,核糖体应激激活的p38信号下调了NRF2和NF-κB,它们都是FPN-1转录的正转录调控因子。这项研究提供了分子证据,证明核糖体功能障碍是铁血非肠道环境血色素沉着病的重要病因,可通过核糖体功能障碍调节铁的生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号